Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
PLEASANTON, Calif., Jan. 04, 2018 -- The Cooper Companies, Inc. (NYSE:COO) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2018, to stockholders of record on January 23, 2018.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 11,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-D
Source: The Cooper Companies, Inc.
CONTACT:
Kim Duncan
Vice President, Investor Relations
[email protected]
